We are live on ! Find out more
VYNE icon

VYNE Therapeutics
VYNE

41 hedge funds and large institutions have $1.1M invested in VYNE Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 41 → 41 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.09% less ownership

Funds ownership: 0.79% → 0.7% (-0.09%)

40% less capital invested

Capital invested by funds: $1.84M → $1.1M (-$738K)

67% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 15

Holders
41
Holders Change
–
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$64.2K
2
UBS Group
UBS Group
Switzerland
+$9.82K
3
TSS
Two Sigma Securities
New York
+$4.2K
4
SG
StoneX Group
New York
+$3.07K
5
TFA
Tobias Financial Advisors
Florida
+$2.44K

Top Sellers

Rank Fund Capital Flow
1
DA
DSC Advisors
Illinois
-$244K
2
VF
Virtu Financial
New York
-$14K
3
Renaissance Technologies
Renaissance Technologies
New York
-$13.8K
4
Citadel Advisors
Citadel Advisors
Florida
-$7.25K
5
Jane Street
Jane Street
New York
-$7.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$2.77K -$7.14K -1,787 -64%
LPL Financial
27
LPL Financial
California
$2.54K -$88 -22 -2%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2.47K -$1.87K -469 -34%
SG
29
StoneX Group
New York
$2.08K +$3.07K +769 New
Mariner
30
Mariner
Kansas
$2K -$328 -82 -11%
TFA
31
Tobias Financial Advisors
Florida
$1.65K +$2.44K +611 New
Russell Investments Group
32
Russell Investments Group
United Kingdom
$506 – – –
First Manhattan
33
First Manhattan
New York
$383 – – –
Federated Hermes
34
Federated Hermes
Pennsylvania
$344 – – –
Wells Fargo
35
Wells Fargo
California
$235 -$220 -55 -39%
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$131 – – –
SPIA
37
Steward Partners Investment Advisory
New York
$95 -$100 -25 -42%
IRC
38
Investors Research Corp
Georgia
$23 – – –
VF
39
Virtu Financial
New York
– -$14K -3,415 Closed
Rockefeller Capital Management
40
Rockefeller Capital Management
New York
– -$288 -72 -95%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– +$28 +7 +19%
1
2

VYNE Hedge Fund Activity: Q4 2022 in Review

41 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in VYNE Therapeutics (VYNE) for Q4 2022, worth a combined $1.1M — down 40% from $1.84M a quarter earlier.

Fund positioning in VYNE was balanced in Q4 2022: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 15 trimmed.

The largest buyer was Millennium Management, adding an estimated $64.2K. The largest seller was DSC Advisors, cutting an estimated $244K.

  • 41 institutional investors held VYNE Therapeutics (VYNE) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $1.1M of VYNE Therapeutics stock for Q4 2022, down 40% quarter-over-quarter.
  • 4 funds opened new VYNE Therapeutics positions in Q4 2022 and 4 closed out, a net change of 0 holders.
  • The largest VYNE Therapeutics buyer in Q4 2022 was Millennium Management, an estimated $64.2K added.
  • The largest VYNE Therapeutics seller in Q4 2022 was DSC Advisors, an estimated $244K sold.

Based on aggregated 13F filings for Q4 2022.